December 19, 2019—The Society for Vascular Surgery (SVS) announced that the findings from a quality-of-life (QOL) analysis of data from the ATTR
April 17, 2025—Venova Medical announced the completion of patient enrollment for the company’s VENOS-2 early feasibility study. Accordi
April 14, 2025—With a focus on endovascular aneurysm repair (EVAR) for abdominal aortic aneurysms (AAAs) and thoracoabdominal aortic aneurysms (
April 16, 2025—Anaconda Biomed, SL, announced the publication of results of the ANAIS study, which evaluated the safety and performance of the c
Reflections on a recent NEJM publication highlight the importance of identifying and addressing the pathologic process of venous hypertension for optimizing clinical improvement in chronic…
April 15, 2025—Imperative Care, Inc. announced it will fund an investigator-initiated, multicenter, randomized controlled trial (RCT) comparing
April 15, 2025—Terumo Neuro, a wholly owned subsidiary of Terumo Corporation, announced that the company’s dual-layer micromesh carotid st
April 14, 2025—Delcath Systems, Inc., an interventional oncology company focused on the treatment of primary and metastatic liver cancers, annou
Approach to hypersensitivity management after endovenous ablation.
April 9, 2025—Microbot Medical Inc., a precommercial-stage medical technology company that is developing the Liberty endovascular robotic system
Developing artificial intelligence models for precision medicine, use for endoleak and spinal cord ischemia prediction, procuring the right data and what to do if data…
